Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02496663 |
|---|---|
| Brief Title: | Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor |
| First Submitted : | July 9, 2015 |
| First Submitted that Met QC Criteria : | July 9, 2015 |
| First Posted : | July 14, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 7, 2024 |
| Last Update Posted : | May 8, 2024 |